News MSD aims to plug dengue fever vaccine gap in US MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.
News Wockhardt has high hopes for novel antibiotic Zaynich Wockhardt has completed a pre-filing meeting with the FDA and is preparing to submit its novel antibiotic Zaynich in the US and Europe.
News Has mRNA delivered a breakthrough in quest for HIV cure? A new way to deliver mRNA to T cells could allow HIV that is hiding away to be exposed and targeted with antiretroviral therapies, say scientists.
News Roche takes new antibiotic into phase 3 for 'urgent threat' Roche is moving its antibiotic zosurabalpin into phase 3 for CRAB, potentially a big step forward in the fight against antimicrobial resistance.
News US is planning $500m project on 'universal vaccines;' WSJ The US will spend $500m to develop universal vaccines against multiple virus variants, while planned changes to testing rules are raising concerns.
News France probes side effects with Valneva's chikungunya jab France's national public health agency has halted dosing of Valneva's chikungunya vaccine in older people while it investigates a safety signal.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face